Utility of interrupting antiretroviral treatment before HIV drug resistance testing in patients with persistently detectable low-level viremia

被引：0

作者：

Sirvent, JLG ^{[1
]}

Socas, MMA ^{[1
]}

Calzadilla, CH ^{[1
]}

Lirola, AML ^{[1
]}

Valls, MRA ^{[1
]}

机构：

[1] Hosp Univ Canarias, Lab Serv, Infect Dis Serv, Tenerife, Spain

来源：

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2005年 / 40卷 / 01期

关键词：

D O I：

10.1097/01.qai.0000174650.33159.22

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：111 / 113

页数：3

共 50 条

[41] Performance of HIV-1 Drug Resistance Testing at Low-Level Viremia and Its Ability to Predict Future Virologic Outcomes and Viral Evolution in Treatment-Naive Individuals
Gonzalez-Serna, A.
Min, J. E.
Woods, C.
Chan, D.
Lima, V. D.
Montaner, J. S. G.
Harrigan, P. R.
Swenson, L. C.
CLINICAL INFECTIOUS DISEASES, 2014, 58 (08) : 1165 - 1173
[42] The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
Gandhi, Rajesh T.
Zheng, Lu
Bosch, Ronald J.
Chan, Ellen S.
Margolis, David M.
Read, Sarah
Kallungal, Beatrice
Palmer, Sarah
Medvik, Kathy
Lederman, Michael M.
Alatrakchi, Nadia
Jacobson, Jeffrey M.
Wiegand, Ann
Kearney, Mary
Coffin, John M.
Mellors, John W.
Eron, Joseph J.
PLOS MEDICINE, 2010, 7 (08)
[43] Feasibility and clinical relevance of HIV-1 drug resistance testing in patients with low-level viraemia in South Africa
Bangalee, Avania
Hans, Lucia
Steegen, Kim
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (10) : 2659 - 2665
[44] Significance and Clinical Management of Persistent Low-Level Viremia and Very-Low-Level Viremia in HIV-1-Infected Patients
Ryscavage, Patrick
Kelly, Sean
Li, Jonathan Z.
Harrigan, P. Richard
Taiwo, Babafemi
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (07) : 3585 - 3598
[45] Detection of clinically relevant antiretroviral drug resistance mutations among treated patients undergoing testing at low levels of viremia
Geretti, A. M.
Phillips, A. N.
Kaye, S.
Booth, C.
Mackie, N. E.
ANTIVIRAL THERAPY, 2009, 14 (04) : A60 - A60
[46] Full Viral Suppression, Low-Level Viremia, and Quantifiable Plasma HIV-RNA at the End of Pregnancy in HIV-Infected Women on Antiretroviral Treatment
Baroncelli, Silvia
Pirillo, Maria F.
Tamburrini, Enrica
Guaraldi, Giovanni
Pinnetti, Carmela
Antoni, Anna Degli
Galluzzo, Clementina M.
Stentarelli, Chiara
Amici, Roberta
Floridia, Marco
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2015, 31 (07) : 673 - 678
[47] Residual Viremia Is Preceding Viral Blips and Persistent Low-Level Viremia in Treated HIV-1 Patients
Hofstra, Laura Marije
Mudrikova, Tania
Stam, Arjen J.
Otto, Sigrid
Tesselaar, Kiki
Nijhuis, Monique
Wensing, Annemarie M. J.
PLOS ONE, 2014, 9 (10):
[48] Treatment outcomes of low-level viremia among adults living with HIV on dolutegravir-based first line antiretroviral therapy in Botswana
Bareng, Ontlametse T.
Moyo, Sikhulile
Mudanga, Mbatshi
Sebina, Kagiso
Koofhethile, Catherine
Choga, Wonderful
Gobe, Irene
Motswaledi, Modisa
Maruapula, Docas
Moraka, Natasha
Musonda, Rosemary
Nkomo, Joseph
Ramaabya, Dinah
Chebani, Tony
Makuruetsa, Penny
Makhema, Joseph
Gaseitsiwe, Simani
BMJ GLOBAL HEALTH, 2023, 8 (SUPPL_10): : A24 - A24
[49] Improved Viral Suppression After Treatment Optimization in HIV-Infected Patients With Persistent Low-Level Viremia
McConnell, Michael J.
Mier-Mota, Julian
Flor-Parra, Fernando
Martinez-Fernandez, Francisco J.
Lopez-Cortes, Luis F.
Viciana, Pompeyo
Fernandez-Cuenca, Felipe
Perez-Romero, Pilar
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 58 (05) : 446 - 449
[50] Low-level Viremia in Treated HIV-1 Infected Patients: Advances and Challenges
Bai, Ruojing
Lv, Shiyun
Wu, Hao
Dai, Lili
CURRENT HIV RESEARCH, 2022, 20 (02) : 111 - 119

← 1 2 3 4 5 →